Central Line-Associated Bloodstream Infection QI Project
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNYU Langone Health
About this trial
This study evaluates a daily electronic health record (EHR) alert designed to reduce unnecessary central venous catheter (CVC) use among hospitalized adults. The alert identifies patients with an active CVC and no documented indication, prompting the first-contact provider to document line necessity. The study compares alert and a secure chat intervention to usual care, with the goal of reducing unnecessary line days and related CLABSI risk.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Not hospice patient class
Active central line for at least 24 hours
Disqualifiers
No active central line
Central line present for less than 24 hours
Trial population
Adult inpatients with an active central venous catheter for at least 24 hours who meet alert eligibility criteria during the study period
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
30 Participants
are grouped into 2 trial groupsGroup A: Usual Care
Group B: Secure Chat + Alert Cohort
Trial outcomes
Primary outcomes
1
Total number of central line days without a documented indication
Time frame
Up to Month 3Secondary outcomes
1
Number of femoral central lines in place for more than 2 days
Time frame
Up to Month 32
Number of non-tunneled hemodialysis catheters without an active hemodialysis or continuous renal replacement therapy order
Time frame
Up to Month 3Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: